Primary Aldosteronism Subtype Diagnosis: Adrenal Venous Sampling vs. CXCR4 PET CT
Endocrinology, Diabetes & Metabolism · 2026-09 · 9 (5)
DOI: 10.1002/edm2.70254 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Endocrinology, Diabetes & Metabolism, online erschienen am 07.09.2026. Verfasst von Shengzhuo Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Urology Department, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Receptors, CXCR4, Hyperaldosteronism, Adrenal Glands, Positron Emission Tomography Computed Tomography. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Department of Sichuan Province, Postdoctoral Fund of West China Hospital, National Natural Science Foundation of China.
Abstract (Originalsprache)
Purpose
To explore the clinical value of adrenal venous sampling (AVS) and CXCR4‐directed 68 Ga‐pentixafor PET/CT in the subtype diagnosis of primary aldosteronism (PA), with postsurgical blood pressure control and biochemical cure as primary endpoints, and to compare the accuracy and practicability of the two methods.
Methods
A retrospective cohort study was conducted in PA patients undergoing unilateral adrenalectomy at West China Hospital between February 2023 and June 2025. Patients were divided into the AVS and CXCR4 imaging groups. The primary outcome was the clinical and biochemical success rate according to the Primary Aldosteronism Surgical Outcome (PASO) criteria. In the subgroup with both procedures, AVS was considered the reference standard to assess the diagnostic efficacy of CXCR4.
Results
A total of 160 patients completed the trial. According to the PASO criteria, the total biochemical success rate was 93.1%, among which the complete biochemical success rate in the AVS group was 84.1%, and in the CXCR4 group it was 93.1% ( p = 0.091); the total clinical success rate was 82.5%, with a complete clinical success rate of 40.9% in the AVS group and 30.3% in the CXCR4 group ( p = 0.412). There were no statistically significant differences between the two groups. In 16 patients with both examinations, CXCR4 showed a sensitivity of 70.0%, specificity of 83.3%, accuracy of 75.0%, and moderate agreement with AVS.
Conclusion
CXCR4 showed no statistical difference from AVS in diagnostic and prognostic outcomes in this study. However, discordance in multinodular disease indicates that molecular imaging cannot fully reflect the heterogeneity of aldosterone secretion. This finding requires verification in a larger cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Urology Department, West China Hospital, Sichuan University, Chengdu, China.
- West China School of Medicine, Sichuan University, Chengdu, Sichuan, China.
- Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Zizhong County People's Hospital, Neijiang City, Sichuan, China.
ORCID-Profile: Yifan Zhang, Huijun Zhou
Förderung
- Science and Technology Department of Sichuan Province
- Postdoctoral Fund of West China Hospital
- National Natural Science Foundation of China
Zitieren
APA
Liu, S., Zhang, Y., Liu, X., Zhou, H., Shen, S., Yin, N., & Zhu, Y. (2026). Primary Aldosteronism Subtype Diagnosis: Adrenal Venous Sampling vs. CXCR4 PET CT. Endocrinology, Diabetes & Metabolism, 9(5). https://doi.org/10.1002/edm2.70254
Vancouver
Liu S, Zhang Y, Liu X, Zhou H, Shen S, Yin N, et al. Primary Aldosteronism Subtype Diagnosis: Adrenal Venous Sampling vs. CXCR4 PET CT. Endocrinology, Diabetes & Metabolism. 2026;9(5). doi:10.1002/edm2.70254
BibTeX
@article{Liu2026,
author = {Liu, Shengzhuo and Zhang, Yifan and Liu, Xiaoyang and Zhou, Huijun and Shen, Sikui and Yin, Ning and Zhu, Yuchun},
title = {Primary Aldosteronism Subtype Diagnosis: Adrenal Venous Sampling vs. CXCR4 PET CT},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2026},
volume = {9},
number = {5},
doi = {10.1002/edm2.70254}
}
EUVIMED